Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
All Genders
ID06575712

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

Led by Duke University · Updated on 2026-04-09

177

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

D

Duke University

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a hybrid in-person and mobile health (mHealth) coping skills training and activity coaching program called Step Up. This study focuses on patients who have undergone hematopoietic stem cell transplant (HCT) or CAR T cell therapy for blood cancers like leukemia, lymphoma, or multiple myeloma. The goal is to help these patients manage symptoms such as pain, fatigue, and stress to improve their physical activity and reduce disability. Participants in the Step Up group will complete seven sessions over 7 to 14 weeks, including three in-person sessions at the hospital or clinic and four video sessions after discharge. These sessions include coping skills training and occupational therapy-led activity coaching. The study uses wearable activity trackers and a mobile app to monitor daily symptoms, activity, and biometric data, giving personalized real-time feedback. A comparison group receives usual medical care plus educational videos through an app but not the Step Up program. During the study, participants will undergo assessments at baseline, post-intervention (2-3 months), 3-month, and 6-month follow-ups. These include measures of physical disability using the Functional Assessment of Cancer Therapy and the Six-Minute Walk Test, as well as evaluations of fatigue, pain, psychological distress, daily step counts, and self-efficacy for symptom management. The study aims to understand how symptoms affect activity and to test the effect of the Step Up program on digital biomarkers like heart rate and sleep time. Participant involvement will last several months with ongoing monitoring and support.

CONDITIONS

Brief Title

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Received an autologous hematopoietic stem cell transplant or CAR T cell therapy for a blood cancer such as leukemia, lymphoma, or multiple myeloma
  • Age over 18 years
  • Self-reported fatigue, pain, or psychological distress, with at least two symptoms rated above 3 on a 0-10 scale
  • Life expectancy greater than 12 months
Not Eligible

You will not qualify if you...

  • Cognitive impairment such as dementia
  • Brain metastases
  • Severe psychiatric conditions that make safe participation impossible
  • Inability to speak or understand English

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 7 to 14 weeks

Participants in the Step Up group complete 7 sessions of coping skills training and activity coaching delivered both in-person and via videoconferencing over 7 to 14 weeks. Participants in the Usual Care Plus group receive educational videos via an app over the same period.

3 in-person sessions and 4 videoconference sessions for Step Up participants; educational videos accessed weekly for 7 weeks for Usual Care Plus participants

Follow-up

Duration - Up to 6 months after treatment

Participants complete assessments to measure changes in physical disability, symptoms, activity levels, and self-efficacy at multiple time points following the intervention.

Assessments at post-intervention (2-3 months), 3 months, and 6 months follow-up

Trial Site Locations

Total: 1 location

1

Duke Cancer Institute

Durham, North Carolina, United States, 27705

Actively Recruiting

Loading map...

Research Team

A

Allison Diachina

S

Sarah Kelleher, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

A Study of A-CAR028 Treatment in Subjects With Relapsed or R...

Acute Myeloid Leukemia (AML)

Actively Recruiting

1 location

Dual Target CAR-T Cell Treatment for Refractory Systemic Lup...

CAR-T Cell Therapy

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here